FISIOPATOLOGÍA Y FARMACOLOGÍA
Escuela de doctorado
Eva Mª
Villaron Ríos
Investigadora desde null
Publicaciones en las que colabora con Eva Mª Villaron Ríos (22)
2023
-
Autologous mesenchymal stem cell transplantation for spinal fusion: 10 years follow-up of a phase I/II clinical trial
Stem cell research & therapy, Vol. 14, Núm. 1, pp. 78
-
Autologous mesenchymal stromal cells embedded with Tissucol Duo® for prevention of air leak after anatomical lung resection: results of a prospective phase I/II clinical trial with long-term follow-up
Stem Cell Research and Therapy, Vol. 14, Núm. 1
-
Long-Term Results of a Phase I/II Clinical Trial of Autologous Mesenchymal Stem Cell Therapy for Femoral Head Osteonecrosis
Journal of Clinical Medicine, Vol. 12, Núm. 6
2022
-
Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome
Frontiers in Immunology, Vol. 13
2019
-
Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: Results of a prospective phase I/II clinical trial with long-term follow-up
Stem Cell Research and Therapy, Vol. 10, Núm. 1
2018
-
Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: Long-term follow up of a multicenter randomized controlled clinical trial (phase I/II)
Journal of Translational Medicine
-
Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger's disease)
Stem Cell Research and Therapy, Vol. 9, Núm. 1
2016
2014
-
Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation, Vol. 20, Núm. 10, pp. 1580-1585
2012
-
Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation
Transfusion, Vol. 52, Núm. 5, pp. 1086-1091
-
Optimisation of mesenchymal stromal cells karyotyping analysis: Implications for clinical use
Transfusion Medicine, Vol. 22, Núm. 2, pp. 122-127
2009
-
Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome
Leukemia, Vol. 23, Núm. 4, pp. 664-672
-
Prospective comparative analysis of the angiogenic capacity of monocytes and CD1331 cells in a murine model of hind limb ischemia
Cytotherapy, Vol. 11, Núm. 8, pp. 1041-1051
2008
-
Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification
Experimental Hematology, Vol. 36, Núm. 8, pp. 1014-1021
2007
-
In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression
Transfusion and Apheresis Science, Vol. 37, Núm. 2, pp. 145-156
-
Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers
Cytotherapy, Vol. 9, Núm. 1, pp. 14-22
2005
-
Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors
Haematologica, Vol. 90, Núm. 3, pp. 353-359
-
Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: A comparison with their respective sibling donors
Biology of Blood and Marrow Transplantation, Vol. 11, Núm. 5, pp. 354-361
-
Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability
Experimental Hematology, Vol. 33, Núm. 8, pp. 935-943